Meta Pixel

News and Announcements

Atomo Diagnostics Wins State Funding to Make HIV Self Test

  • Published November 30, 2015 11:37AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

November 28, 2015, PR.com

Atomo Diagnostics is delighted to announce that the company has been awarded a grant of A$1.8 million (US$1.3M) from the New South Wales Medical Device Fund 2015-2016 for the development of a self-test for rapid detection of HIV. The Atomo HIV Self Test will be easier to use than any HIV self-test available globally, and will provide users with clear and accurate test results within minutes.

Atomo Diagnostics is a Sydney-headquartered healthcare company that designs, develops and commercialises rapid diagnostic tests that offer best-in-class safety and ease-of-use. Atomo is Australia’s only manufacturer of rapid diagnostic tests for detection of HIV, and currently sells most of its tests to professional users in Africa.

The NSW Medical Device Fund is an annual merit-based commercialisation programme run by the NSW Government Department of Health. The Fund helps to promote and support the development of new and innovative medical devices in NSW, with particular focus on technologies that have the potential to provide significant global health benefits.

To read the full story, please click here

Capital Insights
The control layer for the electrified home

THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]

Join over 45,000+ sophisticated investors

Join Now